Variant report

Variant	nsv877759
Chromosome Location	chr3:162303276-162521339
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr3:162387319-162387469	K562	blood:	n/a	n/a
2	ATF2	chr3:162458859-162459451	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr3:162458852-162459444	H1-hESC	embryonic stem cell:	n/a	n/a
4	BATF	chr3:162426813-162426972	GM12878	blood:	n/a	n/a
5	BRCA1	chr3:162343607-162343624	Hela-S3	cervix:	n/a	n/a
6	CBX3	chr3:162437445-162437946	HCT-116	colon:	n/a	n/a
7	CEBPB	chr3:162447443-162447905	IMR90	lung:	n/a	n/a
8	CEBPB	chr3:162318597-162318906	IMR90	lung:	n/a	chr3:162318771-162318782 chr3:162318770-162318783 chr3:162318770-162318783 chr3:162318770-162318781 chr3:162318772-162318781
9	CEBPB	chr3:162375783-162376266	MCF-7	breast:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
10	CEBPB	chr3:162476765-162477042	HepG2	liver:	n/a	chr3:162476875-162476886
11	CEBPB	chr3:162463221-162463465	Hela-S3	cervix:	n/a	n/a
12	CEBPB	chr3:162363990-162364207	A549	lung:	n/a	chr3:162364112-162364123 chr3:162364019-162364030
13	CEBPB	chr3:162407165-162407420	HepG2	liver:	n/a	n/a
14	CEBPB	chr3:162375834-162376167	IMR90	lung:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
15	CEBPB	chr3:162446794-162447048	Hela-S3	cervix:	n/a	chr3:162446911-162446922
16	CEBPB	chr3:162493943-162494295	H1-hESC	embryonic stem cell:	n/a	n/a
17	CEBPB	chr3:162476766-162477058	A549	lung:	n/a	chr3:162476875-162476886
18	CEBPB	chr3:162493941-162494308	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr3:162491565-162491768	A549	lung:	n/a	n/a
20	CEBPB	chr3:162375773-162376159	MCF-7	breast:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
21	CEBPB	chr3:162323772-162323878	H1-hESC	embryonic stem cell:	n/a	n/a
22	CEBPB	chr3:162476750-162477034	IMR90	lung:	n/a	chr3:162476875-162476886
23	CEBPB	chr3:162318973-162319104	HepG2	liver:	n/a	n/a
24	CEBPB	chr3:162493987-162494268	A549	lung:	n/a	n/a
25	CEBPB	chr3:162363967-162364264	HepG2	liver:	n/a	chr3:162364112-162364123 chr3:162364019-162364030
26	CEBPB	chr3:162446913-162446930	H1-hESC	embryonic stem cell:	n/a	n/a
27	CEBPB	chr3:162375840-162376163	A549	lung:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
28	CEBPB	chr3:162447548-162447825	A549	lung:	n/a	n/a
29	CEBPB	chr3:162447411-162447959	A549	lung:	n/a	n/a
30	CEBPB	chr3:162446780-162447056	HepG2	liver:	n/a	chr3:162446911-162446922
31	CEBPB	chr3:162395700-162395948	A549	lung:	n/a	n/a
32	CEBPB	chr3:162375820-162376163	HepG2	liver:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
33	CEBPB	chr3:162458978-162459479	H1-hESC	embryonic stem cell:	n/a	n/a
34	CEBPB	chr3:162446791-162447068	A549	lung:	n/a	chr3:162446911-162446922
35	CEBPB	chr3:162364026-162364261	Hela-S3	cervix:	n/a	chr3:162364112-162364123
36	CEBPB	chr3:162375805-162376171	Hela-S3	cervix:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
37	CEBPB	chr3:162490538-162490834	HepG2	liver:	n/a	chr3:162490691-162490702
38	CEBPB	chr3:162397582-162397594	A549	lung:	n/a	n/a
39	CEBPB	chr3:162426766-162427111	A549	lung:	n/a	n/a
40	CEBPB	chr3:162447493-162447822	Hela-S3	cervix:	n/a	n/a
41	CEBPB	chr3:162375910-162376151	ECC-1	luminal epithelium:	n/a	chr3:162375998-162376009 chr3:162375998-162376011 chr3:162375960-162375971 chr3:162375999-162376010 chr3:162375998-162376011 chr3:162375998-162376009
42	CEBPB	chr3:162446775-162447096	IMR90	lung:	n/a	chr3:162446911-162446922
43	CEBPB	chr3:162493953-162494306	IMR90	lung:	n/a	n/a
44	CEBPB	chr3:162318673-162319181	HepG2	liver:	n/a	chr3:162318771-162318782 chr3:162318770-162318783 chr3:162318770-162318783 chr3:162318770-162318781 chr3:162318772-162318781
45	CEBPB	chr3:162328054-162328397	H1-hESC	embryonic stem cell:	n/a	n/a
46	CHD2	chr3:162492211-162492255	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTCF	chr3:162495000-162495150	GM12867	blood:	n/a	n/a
48	CTCF	chr3:162517820-162517970	HRPEpiC	eye:	n/a	n/a
49	CTCF	chr3:162415731-162416177	MCF-7	breast:	n/a	n/a
50	CTCF	chr3:162383160-162383310	HEK293	kidney:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:162317560-162317610	U87	brain:	n/a
2	chr3:162421027-162421077	SK-N-MC	brain:	n/a
3	chr3:162317560-162317610	NH-A	brain:	n/a
4	chr3:162420994-162421044	PrEC	prostate:	n/a
5	chr3:162420994-162421044	BJ	skin:	n/a
6	chr3:162317560-162317610	Hela-S3	cervix:	n/a
7	chr3:162421027-162421077	NHBE	bronchial:	n/a
8	chr3:162317560-162317610	BJ	skin:	n/a
9	chr3:162317560-162317610	SKMC	muscle:	n/a
10	chr3:162317560-162317610	ovcar-3	ovarian:	n/a
11	chr3:162421027-162421077	ovcar-3	ovarian:	n/a
12	chr3:162421027-162421077	AG04450	lung:	fetal
13	chr3:162420994-162421044	AG04450	lung:	fetal
14	chr3:162420994-162421044	Caco-2	colon:	n/a
15	chr3:162421027-162421077	NB4	blood:	n/a
16	chr3:162317560-162317610	HCF	heart:	n/a
17	chr3:162420994-162421044	HRE	kidney:	n/a
18	chr3:162317560-162317610	HCPEpiC	choroid plexus:	n/a
19	chr3:162421027-162421077	AG09319	gingival:	n/a
20	chr3:162420994-162421044	AG10803	skin:	n/a
21	chr3:162421027-162421077	HCPEpiC	choroid plexus:	n/a
22	chr3:162420994-162421044	RPTEC	kidney:	n/a
23	chr3:162317560-162317610	ProgFib	skin:	n/a
24	chr3:162420994-162421044	HUVEC	blood vessel:	n/a
25	chr3:162420994-162421044	HepG2	liver:	n/a
26	chr3:162420994-162421044	NT2-D1	testis:	n/a
27	chr3:162420994-162421044	PANC-1	pancreas:	n/a
28	chr3:162420994-162421044	GM12891	blood:	n/a
29	chr3:162317560-162317610	NT2-D1	testis:	n/a
30	chr3:162421027-162421077	NT2-D1	testis:	n/a
31	chr3:162421027-162421077	GM12878	blood:	n/a
32	chr3:162420994-162421044	IMR90	lung:	fetal
33	chr3:162317560-162317610	HRPEpiC	eye:	n/a
34	chr3:162421027-162421077	Hepatocyte	liver:	n/a
35	chr3:162421027-162421077	HMEC	breast:	n/a
36	chr3:162317560-162317610	HL-60	blood:	n/a
37	chr3:162317560-162317610	PANC-1	pancreas:	n/a
38	chr3:162421027-162421077	PFSK-1	brain:	n/a
39	chr3:162420994-162421044	HCM	heart:	n/a
40	chr3:162317560-162317610	K562	blood:	n/a
41	chr3:162421027-162421077	AG10803	skin:	n/a
42	chr3:162317560-162317610	GM12878	blood:	n/a
43	chr3:162420994-162421044	Hela-S3	cervix:	n/a
44	chr3:162317560-162317610	Jurkat	blood:	n/a
45	chr3:162421027-162421077	GM12891	blood:	n/a
46	chr3:162420994-162421044	HNPCEpiC	eye:	n/a
47	chr3:162317560-162317610	NB4	blood:	n/a
48	chr3:162421027-162421077	HAEpiC	amniotic membrane:	n/a
49	chr3:162421027-162421077	PrEC	prostate:	n/a
50	chr3:162420994-162421044	U87	brain:	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:162471864..162474454-chr3:162482441..162485010,2	MCF-7	breast:
2	chr3:162468849..162471720-chr3:162897232..162899564,2	K562	blood:
3	chr3:162449508..162452375-chr3:162459605..162462257,2	MCF-7	breast:
4	chr3:162475543..162478495-chr3:162480272..162482533,2	MCF-7	breast:
5	chr3:162399486..162401021-chr3:162401571..162403144,2	MCF-7	breast:
6	chr3:162486396..162487274-chr3:162497260..162497768,2	MCF-7	breast:
7	chr3:162475543..162478495-chr3:162480272..162482533,2	MCF-7	breast:
8	chr3:162307801..162310469-chr3:162314134..162316904,3	MCF-7	breast:
9	chr3:162307801..162310469-chr3:162314134..162316904,3	MCF-7	breast:
10	chr3:162449508..162452375-chr3:162459605..162462257,2	MCF-7	breast:
11	chr3:162367684..162370185-chr3:162370811..162372665,2	MCF-7	breast:
12	chr3:162399486..162401021-chr3:162401571..162403144,2	MCF-7	breast:
13	chr3:162411048..162413287-chr3:162414403..162417401,2	MCF-7	breast:
14	chr3:162471864..162474454-chr3:162482441..162485010,2	MCF-7	breast:
15	chr3:162118223..162119105-chr3:162517137..162517997,2	MCF-7	breast:
16	chr3:162486396..162487274-chr3:162497260..162497768,2	MCF-7	breast:
17	chr3:162394370..162397355-chr3:162401132..162403109,2	MCF-7	breast:
18	chr3:162268890..162270552-chr3:162314764..162316650,2	MCF-7	breast:
19	chr3:162367684..162370185-chr3:162370811..162372665,2	MCF-7	breast:
20	chr3:162494680..162495563-chr3:162760633..162761552,3	MCF-7	breast:
21	chr3:162394370..162397355-chr3:162401132..162403109,2	MCF-7	breast:
22	chr3:162411048..162413287-chr3:162414403..162417401,2	MCF-7	breast:
23	chr15:52605031..52607219-chr3:162453213..162454978,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-OTOL1-2	chr3:162443543-162443656	NONHSAT093026
2	lnc-OTOL1-8	chr3:162455438-162455542	NONHSAT093025
3	lnc-OTOL1-2	chr3:162442527-162442700	NONHSAT093026
4	lnc-OTOL1-8	chr3:162441830-162442283	NONHSAT093025

Variant related genes	Relation type
ENSG00000243044	TF binding region
ENSG00000243044	CpG island

Extended variants
information (count: 7697 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:7697 , 50 per page) page: 1 2 3 4 5 6 7 ... 154

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2086092	chr3:162303276-162303277	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs2086091	chr3:162303306-162303307	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs546275160	chr3:162303329-162303330	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs62291537	chr3:162303376-162303377	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs147269204	chr3:162303378-162303379	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs540789451	chr3:162303410-162303411	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs183896490	chr3:162303435-162303436	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs529988599	chr3:162303448-162303449	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs549850376	chr3:162303464-162303465	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs563294093	chr3:162303465-162303466	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs531967809	chr3:162303477-162303478	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs188790315	chr3:162303501-162303502	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs565748397	chr3:162303521-162303522	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs534731059	chr3:162303534-162303535	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs548778323	chr3:162303558-162303559	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs9290127	chr3:162303666-162303667	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs191321114	chr3:162303710-162303711	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs140849068	chr3:162303721-162303722	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs577468266	chr3:162303755-162303756	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs13089560	chr3:162303772-162303773	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs571655573	chr3:162303905-162303906	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs114139103	chr3:162303920-162303921	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs372813461	chr3:162303937-162303938	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs541945263	chr3:162303988-162303989	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs34840386	chr3:162303991-162303992	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs367724717	chr3:162304023-162304024	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs557414259	chr3:162304074-162304075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs575604479	chr3:162304090-162304091	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs183915640	chr3:162304162-162304163	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs549938702	chr3:162304167-162304168	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs187078375	chr3:162304217-162304218	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs191936766	chr3:162304218-162304219	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs552174781	chr3:162304235-162304236	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs559419690	chr3:162304239-162304240	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs528178668	chr3:162304249-162304250	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs142403603	chr3:162304284-162304285	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs12696157	chr3:162304307-162304308	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs573021982	chr3:162304312-162304313	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs11712189	chr3:162304324-162304325	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs73029642	chr3:162304359-162304360	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs571021345	chr3:162304381-162304382	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs185130334	chr3:162304440-162304441	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs552924926	chr3:162304446-162304447	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs555475103	chr3:162304468-162304469	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs566569294	chr3:162304475-162304476	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs564802606	chr3:162304500-162304501	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs555397094	chr3:162304535-162304536	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs576747440	chr3:162304591-162304592	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs13316530	chr3:162304605-162304606	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs562511466	chr3:162304626-162304627	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	16608533	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-small cell lung cancer	19010865	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16547154	CNVD
Breast cancer	21364760	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	21785460	CNVD
Sudden cardiac death	19188705	CNVD
Mantle cell lymphoma	19029149	CNVD
Malformation	19546859	CNVD
Schizophrenia	19546859	CNVD
Breast cancer	17133270	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
epilepsy	18472482	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Myxofibrosarcoma	16751306	CNVD
Parkinson disease	21907011	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Ovarian cancer	21781307	CNVD
Bladder cancer	21909424	CNVD
Chordoma	21215367	CNVD

Chromatin state (count:546 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:162302000-162305200	Enhancers	Dnd41	blood
2	chr3:162302600-162303600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr3:162302800-162303400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
4	chr3:162303000-162304800	Enhancers	A549	lung
5	chr3:162303600-162304200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr3:162304200-162304400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
7	chr3:162304200-162304600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr3:162304200-162304600	Enhancers	Rectal Mucosa Donor 31	rectum
9	chr3:162304400-162304800	Enhancers	Fetal Lung	lung
10	chr3:162305200-162305600	Weak transcription	Dnd41	blood
11	chr3:162305600-162305800	Enhancers	Dnd41	blood
12	chr3:162305800-162307600	Weak transcription	Dnd41	blood
13	chr3:162307600-162308400	Genic enhancers	Dnd41	blood
14	chr3:162308400-162308800	Weak transcription	Dnd41	blood
15	chr3:162308800-162310400	Enhancers	Dnd41	blood
16	chr3:162310400-162311400	Weak transcription	Dnd41	blood
17	chr3:162311400-162312800	Genic enhancers	Dnd41	blood
18	chr3:162312800-162314400	Enhancers	Dnd41	blood
19	chr3:162313800-162317200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr3:162314200-162316400	Enhancers	Brain Substantia Nigra	brain
21	chr3:162314200-162317200	Enhancers	Cortex derived primary cultured neurospheres	brain
22	chr3:162314400-162315200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr3:162314400-162315800	Flanking Active TSS	Dnd41	blood
24	chr3:162314400-162316400	Enhancers	Brain Hippocampus Middle	brain
25	chr3:162314400-162318800	Weak transcription	HSMM	muscle
26	chr3:162314800-162315200	Enhancers	iPS-20b Cell Line	embryonic stem cell
27	chr3:162314800-162315600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
28	chr3:162314800-162315600	Enhancers	Brain Angular Gyrus	brain
29	chr3:162314800-162316200	Enhancers	Brain Cingulate Gyrus	brain
30	chr3:162314800-162316600	Enhancers	Brain Anterior Caudate	brain
31	chr3:162314800-162316800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
32	chr3:162315000-162315200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
33	chr3:162315000-162315600	Enhancers	iPS-18 Cell Line	embryonic stem cell
34	chr3:162315000-162315800	Enhancers	ES-I3 Cell Line	embryonic stem cell
35	chr3:162315000-162315800	Enhancers	Brain Inferior Temporal Lobe	brain
36	chr3:162315000-162316200	Enhancers	GM12878-XiMat	blood
37	chr3:162315200-162315600	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
38	chr3:162315200-162316000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
39	chr3:162315200-162316000	Enhancers	Brain Germinal Matrix	brain
40	chr3:162315200-162316600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr3:162315600-162316000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
42	chr3:162315600-162317400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
43	chr3:162315800-162316200	Enhancers	Dnd41	blood
44	chr3:162316000-162316200	Active TSS	iPS-20b Cell Line	embryonic stem cell
45	chr3:162316000-162316400	Enhancers	iPS-18 Cell Line	embryonic stem cell
46	chr3:162316200-162316400	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
47	chr3:162316200-162316400	Flanking Active TSS	GM12878-XiMat	blood
48	chr3:162316200-162316800	Enhancers	iPS-15b Cell Line	embryonic stem cell
49	chr3:162316200-162316800	Enhancers	Fetal Muscle Leg	muscle
50	chr3:162316200-162317000	Enhancers	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links